We expect our cash flow from operations, excluding BioSteel, to be roughly in line with our interest expenses as we exit FY 2024, driven by the completion of our cost reduction program. 2nd, within cash flow from investing activities, Q1 saw an inflow of $83,000,000 from disposition of facilities that we results before the end of September for total proceeds of up to $150,000,000 Net financing activity resulted in an outflow of $133,000,000 Debt pay down during Q1 of $118,000,000 relates to the second pay down of the senior to return loans following the agreement in October of 2022, the $15,000,000 other financing activities related to the lease termination We had $571,000,000 in cash and short term investments and total debt of 1,045,000,000 Subsequent to the quarter end, we've taken additional actions to strengthen the balance sheet and improve liquidity. We settled a full $237,000,000 principal amount of the July 2023 unsecured notes through exchanging $64,000,000 of the notes Into Equity, refinancing $40,000,000 into a new convertible note, which we expect to equitize post our Annual Shareholder Meeting in September and paying the remaining $133,000,000 in cash. We made $93,000,000 of payment to reduce the $100,000,000 of the senior secured term loan principal amount at $0.93 on the dollar and we removed the minimum cash liquidity covenant under this terminal.